Cargando…

Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining

The dysregulation of caspase 4 (CASP4) expression is related to the occurrence, development, and outcome of many malignant tumors; however, its role in clear cell renal cell carcinoma (ccRCC) remains unclear. Herein, we investigated the expression of CASP4 in tumor tissues and its relationship with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Lingfeng, Tian, Zijian, Long, Xingbo, Diao, Tongxiang, Hu, Maolin, Wang, Miao, Zhang, Wei, Zhang, Yaoguang, Wang, Jianye, He, Yuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874118/ https://www.ncbi.nlm.nih.gov/pubmed/33584797 http://dx.doi.org/10.3389/fgene.2020.600248

Ejemplares similares

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial
por: Meng, Lingfeng, et al.
Publicado: (2021)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2021)

m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2022)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer
por: Tian, Zijian, et al.
Publicado: (2021)

Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells
por: Cui, Luwei, et al.
Publicado: (2019)

Comprehensive analysis of 7-methylguanosine and immune microenvironment characteristics in clear cell renal cell carcinomas
por: Xiao, Yu, et al.
Publicado: (2022)

Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect
por: Meng, Lingfeng, et al.
Publicado: (2021)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma
por: Wei, Zhihao, et al.
Publicado: (2022)

Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies
por: Lai, Shicong, et al.
Publicado: (2019)

Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration
por: Long, Xingbo, et al.
Publicado: (2020)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses
por: Hu, Maolin, et al.
Publicado: (2020)

Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment
por: Wei, Xiyi, et al.
Publicado: (2021)

The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
por: Guo, Ergang, et al.
Publicado: (2021)

Single‐cell RNA‐sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone
por: Yan, Qiuxia, et al.
Publicado: (2022)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021)

circEPS15 Overexpression in Hepatocellular Carcinoma Modulates Tumor Invasion and Migration
por: Jiang, Bin, et al.
Publicado: (2022)

Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis
por: Wang, Yuxiong, et al.
Publicado: (2023)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
por: Huang, Xing, et al.
Publicado: (2022)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
por: Gao, Suhua, et al.
Publicado: (2021)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
por: Qin, Huisheng, et al.
Publicado: (2022)

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
por: Nie, Shiwen, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
por: Liu, Zhi, et al.
Publicado: (2023)

Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma
por: Wang, Bin, et al.
Publicado: (2022)

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
por: Chen, Zhuo, et al.
Publicado: (2022)

Nomograms to predict individual prognosis of patients with primary signet ring cell carcinoma of the urinary bladder
por: Ma, Tianming, et al.
Publicado: (2021)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v7gaau6oseac7qb758j1lhm2g